Direct-to-Consumer Laboratory Testing Market (By Product: Medical Genetic Laboratory Testing, Routine Clinical Laboratory Testing; By Test Type: Genetic Testing, COVID-19, Cancer, Diabetes Testing, Disease Risk Assessment Testing, Sexually Transmitted Disease Testing, Routine Testing, Complete Blood Count, CNS-related/Neurological Disease, Thyroid Stimulating Hormone Testing, Other; By Sample Type) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global direct-to-consumer laboratory testing market size was exhibited at USD 3.30 billion in 2022 and is projected to hit around USD 65.05 billion by 2032, growing at a CAGR of 34.73% during the forecast period 2023 to 2032.

Key Pointers:

• North America accounted for more than 48.9% of the total revenue share in 2022.
• By test type, the genetic testing segment has dominated the market in 2022.
• By sample type, the saliva segment has captured a major share of over 40.9% in 2022.

This report analyzes the current scenario and future prospects of the global direct-to-consumer laboratory testing market. Surge in demand for early disease detection & diagnosis coupled with personalized medicines, rise in prevalence of various lifestyle associated and infectious diseases, and increase in geriatric population are key factors that are projected to propel the global market during the forecast period.

The report includes an elaborate executive summary, which provides a snapshot of various segments of the global direct-to-consumer laboratory testing market. It also provides information and data analysis of the direct-to-consumer laboratory testing market about segments based on sample type, test type, end user, and region. the overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the global direct-to-consumer laboratory testing market

The report includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the global direct-to-consumer laboratory testing market the report on the direct-to-consumer laboratory testing market offers market attractiveness analysis of regions and segments

The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global direct-to-consumer laboratory testing market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global direct-to-consumer laboratory testing market.

Direct-to-Consumer Laboratory Testing Market Report Scope

 Direct-to-Consumer Laboratory Testing Market: Key Segments

In terms of sample type, the global direct-to-consumer laboratory testing market has been classified into blood, urine, saliva, and others. The saliva segment is projected to account for a major share of the market. The segment’s dominance can be attributed to increase in the number of DTC testing companies offering saliva-based test kits.

Based on test type, the global direct-to-consumer laboratory testing market has been categorized into genetic testing, disease risk assessment testing, CBC, diabetes testing, TSH testing, and others. The disease risk assessment testing segment has been further split into cancer, STDs, and others. The genetic testing segment dominated the market in 2020. Number of users of DTC test kits for ancestry and health & fitness has increased at a rapid pace. The number of people interested in knowing about their ancestors and family tree has increased, which is also anticipated to increase the demand for DNA test kits, especially in developed countries across the globe.

In terms of end user, the global direct-to-consumer laboratory testing market has been classified into hospitals, clinics, specialty labs, and diagnostic centers. The diagnostic centers segment is projected to account for a major share of the market. Rise in the number of public–private partnerships is expected to drive the segment during the forecast period.

Conducting Several Types of Test with User Convenience Rapidly Attracting New Consumers

The direct-to-consumer (DTC) laboratory testing is an efficient way for consumers to order tests directly from a laboratory without having to work with their healthcare providers. The healthcare industry is shifting their focus from being physician-focused to being consumer-focused. Thus, the DTC lab testing is one of the manifestations of the healthcare sector dreamed in the mid-1900s. An increasing number of patients are moving toward the idea of getting tested without having to go through a lengthy in-clinic process, which is fueling the global direct-to-consumer laboratory testing market. The test results are used to identify previously unknown medical disorders by monitoring an existing health condition. It also helps to access data about personal health aspects. The advancement in DTC lab testing is very essential to increase patient's and individual's engagement in monitoring their healthcare. Thus, it is crucial for laboratory professionals to upgrade their equipment timely to provide precise test results with full understanding.

Presently, many laboratories that offer DTC laboratory testing provide basic tests such as chemistry panels, complete blood count (CBC), pregnancy test, diabetes screening, and blood typing. According to healthcare guidelines in some nations, screening tests can be allowed to facilitate the early detection of diseases. The test helps people to monitor disease and obtain treatment accordingly. Additionally, the tests come provided with descriptions of benefits, risks, and conditions that are also easily understood. The tests offered by DTC laboratories are often waived tests to ensure a low risk of receiving incorrect results. The development in DTC testing has enabled consumers to buy OTC test kits to collect the sample and mail it to a laboratory that performs the test. Growing consumer convenience and rise in awareness among consumers are driving the demand for the global direct-to-consumer laboratory testing market during the forecast period.

DTC Tests Prove Crucial in Critical Response Plan to Fight against COVID-19

The global market in the year 2020 experienced a vast slowdown in almost every industry, owing to the COVID-19 pandemic. Major businesses were asked to postpone or shut their projects in order to contain the spread of coronavirus. Lockdowns, restraint in the supply chain, limited industrial work, and restrictions on the global import-export were implemented by several governments, which hampered industrial growth across the world. However, DTC testing continues to be the backbone in the fight against the coronavirus disease, maintaining containment efforts to decrease the outbreak. The severity of this pandemic and expanding capacity issues linked with the polymerase chain reaction (PCR)-based testing expedited the development of diagnostic solutions to fulfill the demand for mass testing. Various tests of in-vitro diagnostics, including molecular and immunological tests, were the primary focus of DTC testing innovations, which kept the direct-to-consumer laboratory testing market moving through the pandemic in spite of limited resources to perform the tests.

The direct-to-consumer laboratory testing market witnessed an increasing demand for rapid and easy-to-use tests to promote testing outside of laboratory settings. This resulted in the development of immunological tests to detect the presence of viral surface antigens utilizing an antibody. The COVID-19 pandemic caused by the severe acute respiratory syndrome CoV-2 presented an unusual global challenge that reshaped the exercises across the DTC testing innovation landscape. However, the direct-to-consumer laboratory testing market has witnessed a growth in demand amidst the pandemic and is further expected to expand with several people becoming familiar with the process. Furthermore, the growing prevalence of infectious diseases is one of the major factors driving market demand in the post COVID-19. The COVID-19 outbreak similar to other highly contagious infections has led to the rapid development and adoption of DTC testing as part of the critical response plan, propelling the direct-to-consumer laboratory testing market.

Growing Consumer Preference to Perform Tests with Confidentiality Boosts Market Growth

The DTC testing is an interesting extension to the traditional healthcare model for customers desiring information of their health situation and disease risk, ancestry, and their body's expected response to certain prescriptions based on their genotype. The advantages of DTC testing are enticing and driving the direct-to-consumer laboratory testing market. The traditional model of laboratory testing in healthcare begins with the patient identifying the need to see a doctor. Waiting for test results and interpretative data from their doctor can be a source of stress. Reasonably, consumers are ready for a new healthcare model with increased convenience and detailed diagnostic reports without having to go through lengthy procedures. Moreover, the direct-to-consumer laboratory testing menu is ever-expanding, and DTC tests are promoted for a variety of uses. Typical sample types are cheek swabs, saliva or spit, urine, hair, blood spots, or blood. Moreover, there are thousands of DTC tests presently available with more being developed. One common test is DTC genetic tests, which use a saliva sample and is analyzed by genotyping.

The difficulty of scheduling and waiting for an appointment with physician conflicts with consumers' lifestyles. In-office wait times can be long and are negatively associated with patient satisfaction and the likelihood to recommend a physician. On the contrary, DTC companies allow testing without an appointment. Many businesses also offer telehealth benefits for consumers to discuss lab results with a medical professional. Additionally, another appeal of DTC lab tests is confidentiality. Results cannot be shared with anyone unless patients share the result themselves. People may feel more comfortable attempting out testing options for sexually transmitted infections, screening for drugs of abuse, reproduction, and fertility-related tests when the results will be confidential. All these factors are most likely to fuel the demand for the global direct-to-consumer laboratory testing market during the projected timeline.

North America to Lead Direct-to-Consumer Laboratory Testing Market

The rising prevalence of lifestyle-associated and contagious diseases in North America is likely to drive the direct-to-consumer laboratory testing market during the forecast period. Furthermore, increasing consumer awareness and enhancing lifestyles in Europe are expected to boost the direct-to-consumer laboratory testing market in the region.  In addition, the increase in government initiatives to promote enhanced, user-friendly diagnostics and genetic research in countries across Asia is expected to fuel the growth of the direct-to-consumer laboratory testing market.

Direct-to-Consumer Laboratory Testing Market: Regional Outlook

In terms of region, the global direct-to-consumer laboratory testing market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, Switzerland, Russia and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.

The direct-to-consumer laboratory testing market report provides size and forecast for each region and country/sub-region from 2018 to 2032. The CAGR for each of these regions and countries has also been provided for the forecast period from 2023 to 2032. The direct-to-consumer laboratory testing market study also covers the competitive scenario in these regions.

Recent Developments

• VG Acquisitions Corp. (NYSE: VGAC) as well as 23andMe agreed to a signed contract on Feb 2021, to merge through a mixture of equity and currency funding. The company merger gives 23andMe an estimated $3.5 billion asset value.
• A self-collected diagnostic kit for well-being, cardiovascular disease, diabetes, and colon cancer was introduced by Pixel from LabCorp in Nov 2018. In addition to the development of new products, several market participants are choosing various growth methods for corporate investment, like mergers and acquisitions, partnerships and collaborations with other companies and top diagnostic laboratories.

Some of the prominent players in the Direct-to-Consumer Laboratory Testing Market include:

• 23andMe, Inc
• Ambry Genetics Corp.
• Ancestry.com LLC
• Any Lab Test Now, Inc.
• Color Genomics, Inc
• Counsyl, Inc.
• DanteLabs Inc.
• Direct Laboratory Services, LLC
• Eastern Biotech & Life Sciences
• EasyDNA
• EverlyWell, Inc., 
• Full Genomes Corporation, Inc.
• Gene by Gene, Ltd.
• Genecodebook Oy
• Genesis Healthcare Co.
• Genetrainer
• GHC Genetics UK
• HealthCheckUSA
• Home Access Health Corporation
• International Biosciences
• Laboratory Corporation of America Holdings
• LetsGetChecked, Inc.
• Mapmygenome India Limited
• Medichecks.com Ltd.
• MyHeritage Ltd.
• MyMedLab, Inc., 
• Myriad Genetics, Inc.
• Natera, Inc
• OME Care
• Pathway Genomics
• Pixel by LabCorp, 
• Positive Bioscience
• Quest Diagnostics Incorporated, 
• Request A Test, Ltd.
• Shuwen Biotech Co. Ltd.
• Sonora Quest Laboratories, 
• Thryve Inc
• Ulta Lab Tests, LLC, 
• Veritas Genetics
• Vitagene, Inc.
• Walk-In Lab, LLC., 
• WellnessFX, Inc.
• Xcode Life Sciences

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Direct-to-Consumer Laboratory Testing market.

By Product

• Medical Genetic Laboratory Testing
• Routine Clinical Laboratory Testing

By Test Type

• Genetic Testing
• COVID-19
• Cancer
• Diabetes Testing
• Disease Risk Assessment Testing
• Sexually Transmitted Disease Testing
• Routine Testing
• Complete Blood Count
• CNS-related/Neurological Disease
• Thyroid Stimulating Hormone Testing
• Other

By Sample Type

• Blood
• Urine
• Saliva
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)